Evidence map›Paper›PMID 38947746›Full record

ReviewEndoscopic ultrasound

Comments and illustrations of the European Federation of Societies for Ultrasound in Medicine guidelines: Rare pancreatic tumors, ultrasound and contrast-enhanced ultrasound features-Malignant mesenchymal tumors.

Kathleen Möller, Sotirios Ntovas, Michael Hocke, Wei On, Simon M Everett, Barbara Braden, Christian Jenssen, Benjamin Misselwitz, Nan Ge, Siyu Sun and 3 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Endoscopic ultrasound. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Kathleen MöllerMedical Department I/Gastroenterology, Sana Hospital Lichtenberg, Berlin, Germany.
Sotirios NtovasDepartment of Visceral Surgery and Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Michael HockeMedical Department II, Helios Klinikum Meiningen, Germany.
Wei OnDepartment of Gastroenterology, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom.
Simon M EverettDepartment of Gastroenterology, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom.
Barbara BradenTranslational Gastroenterology Unit, Oxford University Hospitals, Oxford, United Kingdom.
Christian JenssenDepartment of Internal Medicine, Krankenhaus Märkisch-Oderland, Strausberg, Germany.
Benjamin MisselwitzDepartment of Visceral Surgery and Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Nan GeDepartment of Endoscopy Center, Shengjing Hospital of China Medical University, Liaoning Province, China.
Siyu SunDepartment of Endoscopy Center, Shengjing Hospital of China Medical University, Liaoning Province, China.
Michael GerberMedical Department I/Gastroenterology, Sana Hospital Lichtenberg, Berlin, Germany.
Siegbert FaissMedical Department I/Gastroenterology, Sana Hospital Lichtenberg, Berlin, Germany.
Christoph F DietrichDepartment Allgemeine Innere Medizin der Kliniken (DAIM) Hirslanden Beau Site, Salem und Permanence, Bern, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rare malignant mesenchymal pancreatic tumors are systematized and reported in this review. The focus is on the appearance on imaging. The present overview summarizes the data and shows that not every pancreatic tumor corresponds to the most common entities of ductal adenocarcinoma or neuroendocrine tumor.

Indexed as

ImagingMalignant mesenchymal pancreatic tumorsPancreatic EGIST

Identifiers

PMID38947746
PMCPMC11213603

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.